Cargando…

Incidence of Venous Thromboembolism in Hospitalized COVID-19 Patients Receiving Thromboprophylaxis

BACKGROUND: The purpose of this study was to investigate the association between anticoagulant dosing intensity in coronavirus disease 2019 (COVID-19) infected patients and its outcomes on venous thromboembolism (VTE) and all-cause mortality. METHODS: This is a retrospective observational study that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jimmy, Martinez, Jenny, Diaz, Daniel, Wolowich, William R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635799/ https://www.ncbi.nlm.nih.gov/pubmed/36406832 http://dx.doi.org/10.14740/jh1036

Ejemplares similares

Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
por: Artifoni, Mathieu, et al.
Publicado: (2020)

The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
por: Zhang, Chuanlin, et al.
Publicado: (2019)

Venous Thromboembolism Among Hospitalized Patients: Incidence and Adequacy of Thromboprophylaxis – A Retrospective Study
por: Ambra, Naseem, et al.
Publicado: (2022)

Anticoagulation strategies in COVID-19 infected patients receiving ECMO support
por: Diaz, Dayne, et al.
Publicado: (2023)

Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors
por: Cook, Deborah, et al.
Publicado: (2008)

Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis
por: Tholin, Birgitte, et al.
Publicado: (2022)

P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS
por: Wang, Y., et al.
Publicado: (2022)

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
por: Aryal, Madan Raj, et al.
Publicado: (2020)

Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis
por: Minet, Clémence, et al.
Publicado: (2015)

Thromboprophylaxis for venous thromboembolism prevention in hip fracture patients
Publicado: (2017)

Analysis of Adherence to Thromboprophylaxis and Incidence of Venous Thromboembolism After Lower Limb Orthopaedic Surgery
por: Benjamin, Miles W, et al.
Publicado: (2021)

Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
por: Willems, R. A. L., et al.
Publicado: (2023)

Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis
por: Chi, Gerald, et al.
Publicado: (2020)

ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism
por: Porres-Aguilar, Mateo
Publicado: (2023)

Awareness of venous thromboembolism and thromboprophylaxis among hospitalized patients: a cross-sectional study
por: Almodaimegh, Hind, et al.
Publicado: (2017)

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

Incidence of venous thromboembolism in hospitalized patients with COVID‐19
por: Middeldorp, Saskia, et al.
Publicado: (2020)

Incidence of Venous Thromboembolism in Hospitalized Patients with COVID-19
por: Middeldorp, S., et al.
Publicado: (2021)

Does thromboprophylaxis prevent venous thromboembolism after major orthopedic surgery?,
por: Akpinar, Evrim Eylem, et al.
Publicado: (2013)

Approach to Thromboprophylaxis for Prevention of Venous Thromboembolism in COVID-19: Global Updates and Clinical Insights from India
por: Ramakrishnan, Nagarajan, et al.
Publicado: (2022)

In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis
por: Mumoli, Nicola, et al.
Publicado: (2021)

Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta‐Analysis
por: Ho, Kwok M., et al.
Publicado: (2015)

Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes
por: Hammami, Rania, et al.
Publicado: (2022)

Incidence of Venous Thromboembolic Events in Hospitalized COVID-19 Patients: A Systematic Review
por: Galllastegui Crestani, Nicolas, et al.
Publicado: (2020)

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
por: Amin, A., et al.
Publicado: (2009)

Thromboprophylaxis and mortality among patients who developed venous thromboembolism in seven major hospitals in Saudi Arabia
por: Al-Hameed, Fahad M., et al.
Publicado: (2017)

The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery
por: Gao, Yuan, et al.
Publicado: (2016)

Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis
por: Ageno, Walter, et al.
Publicado: (2018)

Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
por: Dibiasi, Christoph, et al.
Publicado: (2022)

Is thromboprophylaxis effective in reducing the pulmonary thromboembolism?
por: Rajabi, Fereshteh, et al.
Publicado: (2012)

Incidence of thromboembolism and thromboprophylaxis in medical patients admitted to specialized hospital in Ethiopia using Padua prediction score
por: Asmamaw, Mulugeta, et al.
Publicado: (2022)

Incidence of Venous Thromboembolism and Effect of Anticoagulant Dosing in Hospitalized COVID-19 Patients
por: Kumar, Gagan, et al.
Publicado: (2021)

Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals
por: Martin, Anne-Céline, et al.
Publicado: (2019)

Risk assessment of venous thromboembolism and thromboprophylaxis in pregnant women hospitalized with cancer: Preliminary results from a risk score
por: Hase, Eliane Azeka, et al.
Publicado: (2018)

Venous thromboembolism is rare after total hip and knee joint arthroplasty with long thromboprophylaxis in Finnish fast-track hospitals
por: Moisander, Annette M., et al.
Publicado: (2023)

Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis
por: Zhang, Cong, et al.
Publicado: (2020)

Highlights: burden of venous thromboembolism and role of extended-duration thromboprophylaxis in acute medically ill patients
Publicado: (2018)

Venous Thromboembolism Risk and Thromboprophylaxis Assessment in Surgical Patients Based on Caprini Risk Assessment Model
por: Tadesse, Tamrat Assefa, et al.
Publicado: (2020)

Venous Thromboprophylaxis in Spine Surgery
por: Alvarado, Anthony M., et al.
Publicado: (2019)

Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study
por: Forté, Stéphanie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p7i511bcmru5liev2laflpvve7